Aap Implantate AG. Stock Analysis AAQ1.DE

aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.